An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases

Zeng L.Chow E.Zhang L.Tseng L.-M.Hou M.-F.Fairchild A.Vassiliou V.Jesus-Garcia R.El-Din M.A.A.Kumar A.Forges F.WEI-CHU CHIEBedard G.Bottomley A.2022-05-052022-05-0520120941-4355https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868505660&doi=10.1007%2fs00520-012-1484-x&partnerID=40&md5=d0ce543b8cc77d7352fd05976d1cc712https://scholars.lib.ntu.edu.tw/handle/123456789/609822[SDGs]SDG3[SDGs]SDG17An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastasesjournal article10.1007/s00520-012-1484-x225626072-s2.0-84868505660